Drug
Encorafenib And Binimetinib
Encorafenib And Binimetinib: highest development phase Phase 3, developed by Pierre Fabre. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Pierre Fabre
Trials
| Drug | Phase | Indication |
|---|---|---|
| Encorafenib and Binimetinib NCT05270044 | Phase 3 | Melanoma |
Latest
No recent events.
Follow Encorafenib And Binimetinib on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.